Mindwalk Holdings Corp. · NASDAQ:HYFT
Mindwalk — ImmunoPrecise Antibodies — Q3 2023 Earnings Presentation
17 slides from Mindwalk's earnings presentation, Mar 16, 2023
Slide 1: Earnings Call Third Quarter 2023
Earnings Call Third Quarter 2023 March 16, 2023| NASDAQ:IPA ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an
Slide 2: Disclosures
Disclosures Disclaimer This presentation is not, & nothing in it should be construed as, an offer, invitation or recommendation in respect of ImmunoPrecise Antibodies Ltd. (the “Company”) securities, or an offer, invitation or recommendation to sell, or solicitation of an offer to buy, the facilitie
Slide 3: Fiscal 2023 Q3 Business Update
Fiscal 2023 Q3 Business Update ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an independently operating subsi
Slide 4: BioStrand Updates
BioStrand Updates ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an independently operating subsidiary of Immu
Slide 5: Setting the pace
Setting the pace The biotherapeutic race is undergoing a fundamental transformation. We are at the forefront of accelerating next-gen novel drug discovery. Driven by an unparalleled Superior research The only truly unified intelligence combination data and storage single-platform available — Unlimit
Slide 6: Libera Bio
Libera Bio ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an independently operating subsidiary of ImmunoPreci
Slide 7: CRO Updates
CRO Updates ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an independently operating subsidiary of ImmunoPrec
Slide 8: Talem Updates
Talem Updates ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an independently operating subsidiary of ImmunoPr
Slide 9: TATX-200: TrkBxCD3 T-cell engagers
TATX-200: TrkBxCD3 T-cell engagers Talem update Application(s)/ Value proposition/ Next steps/ Latest milestone reached problem to be solved differentiator(s) commercialization plan Poorly immunogenic solid • Bispecifics demonstrated • Potential first-in-class • In vitro characterization tumors such
Slide 10: TATX-20
TATX-20 Talem update Application(s)/ Value proposition/ Next steps/ Latest milestone reached problem to be solved differentiator(s) commercialization plan • Solid tumors such as • Functional inhibition of TATX- • Potential first-in-class antibody • In vitro characterization ovarian, breast, lung 20R
Slide 11: Fiscal 2023 Q3 Financial Update
Fiscal 2023 Q3 Financial Update ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an independently operating subs
Slide 12: Trends in Revenue and Gross Profit
FISCAL YEAR 2023 Q3 EARNINGS CALL Trends in Revenue and Gross Profit Q3 Revenue Q3 Gross Profit $5,171 $4,815 $4,515 $3,562 $2,964 $2,586 Three Months Ended Three Months Ended Three Months Ended January 31, 2021 January 31, 2022 January 31, 2023 ©2023 ImmunoPrecise Antibodies LTD. All rights reserve
Slide 13: Changes in Operating Expenses
FISCAL YEAR 2023 Q3 EARNINGS CALL Changes in Operating Expenses ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is
Slide 14: Changes in Other Income (Expense)
FISCAL YEAR 2023 Q3 EARNINGS CALL Changes in Other Income (Expense) ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Tale
Slide 15: Changes in Net Loss
FISCAL YEAR 2023 Q3 EARNINGS CALL Changes in Net Loss ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. IPA is a trademark of ImmunoPrecise Antibodies LTD. BioStrand is an independently operating subsidiary of BioStrand, BV. LENSai and HYFTS are trademarks of BioStrand, BV. Talem is an indepe
Slide 16: Changes in Cash Balance
FISCAL YEAR 2023 Q3 EARNINGS CALL Changes in Cash Balance January 31, 2023 $11,324 April 30, 2022 $29,965 $724 ($240) ($1,523) ($17,599) Cash used in Cash used in Cash used in Effect of FX Operating Activities Investing Activities Investing Financing ©2023 ImmunoPrecise Antibodies LTD. All rights re
Slide 17: Fiscal 2023 Q3 Earnings Call
Fiscal 2023 Q3 Earnings Call HUB of Biotherapeutic Intelligence™ http://www.ipatherapeutics.com/ | NASDAQ:IPA ©2023 ImmunoPrecise Antibodies LTD. All rights reserved. ai and HYFTs are trademarks of BioStrand, BV. CONFIDENTIAL ©2023 ImmunoPrecise Antibodies LTD.IPA All is a trademark rights reserved.
ImmunoPrecise Antibodies — Q3 2023 Earnings Presentation on 6ix